Clinically significant anxiety symptoms are common during the postpartum period and frequently complicate the treatment of postpartum depression.  While SSRIs are indicted for the treatment anxiety symptoms, especially when they co-occur with depression, many women may need to use a benzodiazepine for managing more severe symptoms of anxiety or insomnia.Â
A study using indirect comparisons suggests that zuranolone is more effective than the SSRIs for the treatment of PPD. Should it be the first choice for treatment?
This large cohort study from Taiwan indicates that the concomitant use of antidepressants and benzodiazepines during the first trimester is not associated with a substantial increase in risk for overall malformations.
Every week we review the most recent publications in women’s mental health.
Although up to 10% of new fathers may experience mental health challenges, we do not regularly screen this population.
Every week we review the most recent publications in women’s mental health.
A New Drug Application was submitted to the FDA for a novel, nonhormonal dual neurokinin-1 and neurokinin-3 receptor antagonist for the treatment of menopause-related vasomotor symptoms.
Those with depression are at greater risk of experiencing IPV and experiencing IPV is associated with higher levels of depressive symptoms.
This meta-analysis suggests that mind-body therapies are an effective treatment for women victims of violence.
Individuals with postpartum depression are being recruited for a clinical trial of a novel psychedelic compound, RE104.
